Subgroup analysis of the ASPirin in Reducing Events in the Elderly randomized clinical trial suggests aspirin did not improve outcomes in older adults with chronic kidney disease is a research paper published in Kidney International (2020). On theSindex it has a DataRank of 0. It has been cited 28 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIA NIH HHS
Grant: P30 AG024824
NIA NIH HHS
Grant: U01 AG029824
NIA NIH HHS
Grant: U19 AG062682
National Health and Medical Research Council (NHMRC)
Grant: 334047
Randomised double-blind placebo-controlled trial of aspirin in primary prevention of CVD events or dementia in the aged.
National Health and Medical Research Council (NHMRC)
Grant: 1127060
ASPREE Completion Project
National Institutes of Health
Grant: 4U01AG029824-06
ASPirin in Reducing Events in the Elderly
National Institute on Aging
National Health and Medical Research Council
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals